A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's
Running, not enrolling · Phase 2 · Has a placebo group
Conditions studied: Sjogren Disease
In brief
This is a phase 2 study to evaluate the effects of sibeprenlimab 400 mg administered subcutaneously (SC) every 4 (Q4) weeks as an add-on to background treatment in participants with Sjögren's disease.
Key facts
- Study ID
- NCT06928142
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- People needed
- 83
- Starts
- 2025-04-23
- Expected to finish
- 2027-06-04
- Last updated by the study team
- 2026-03-18
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Medvin Clinical Research - Tujunga — Tujunga, California, United States
- Bay Area Arthritis and Osteoporosis — Brandon, Florida, United States
- Clinical Research of West Florida Inc — Clearwater, Florida, United States
- GNP Research - Florida — Cooper City, Florida, United States
- Vantage Clinical Trials - Tampa - ClinEdge - PPDS — Tampa, Florida, United States
- OrthoIllinois, LTD — Rockford, Illinois, United States
- Arnold Arthritis and Rheumatology — Skokie, Illinois, United States
- Ochsner Clinic Foundation — Baton Rouge, Louisiana, United States
- Tufts University School of Dental Medicine — Boston, Massachusetts, United States
- Albuquerque Center for Rheumatology — Albuquerque, New Mexico, United States
- Bradenton Research Center Inc — The Bronx, New York, United States
- DJL Clinical Research PLLC — Charlotte, North Carolina, United States
- STAT Research — Vandalia, Ohio, United States
- Allen Arthritis — Allen, Texas, United States
- Tekton Research, LLC — Austin, Texas, United States
- Advanced Rheumatology of Houston — Houston, Texas, United States
- Accurate Clinical Research - Houston — Houston, Texas, United States
- Accurate Clinical Management, LLC — Katy, Texas, United States
- R & H Clinical Research — Katy, Texas, United States
- Consultorios Médicos Dr. Doreski - Fundacion Respirar - PPDS — Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
- Instituto CER S.A. — Quilmes, Buenos Aires, Argentina
- Instituto Médico de la Fundación Estudios Clínicos — Rosario, Santa Fe Province, Argentina
- Clínica Mayo de U.M.C.B. S.R.L — San Miguel de Tucumán, Tucumán Province, Argentina
- Centro de Investigaciones Médicas Tucumán - PPDS — San Miguel de Tucumán, Tucumán Province, Argentina
- Medvin Clinical Research - Riverside — Riverside, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.